Ayumu Arakawa

9PUBLICATIONS
41CO-AUTHORS
Haematological tumoursMolecular targetsChemotherapyPredictive and prognostic markersAdolescent health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 08, 2026
Efficacy and Safety of Alectinib in Pediatric and Adult Patients with ALK-Altered Advanced Solid Tumors: a phase II TACKLE Trial (NCCH1712/MK003).

|Jul 15, 2026
Preclinical Evaluation of Liposomal Eribulin (E7389-LF) in a Panel of Sarcoma Patient-Derived Xenograft Models.

|Apr 11, 2026
Safety and Efficacy of Vinorelbine and Continuous Low-Dose Cyclophosphamide Chemotherapy in Japanese Pediatric Patients With Relapsed or Refractory Rhabdomyosarcoma.

Risa Yanai, Minako Sugiyama, Bunpei Miyazaki

|Mar 15, 2026
Analysis of the Relationship Between Survival and Postoperative Infection in Patients With Osteosarcoma.

Satoshi Kamio, Koichi Ogura, Kenji Sato

|Sep 09, 2025
Pediatric Alpha-Fetoprotein-Producing Gastric Cancer Presenting With Dysphagia and Multiple Liver Tumors.

Takayuki Hirano, Reina Hoshi, Bin Yamaoka

|Jul 31, 2024
MGMT protein expression is a reliable predictive biomarker for temozolomide-containing chemotherapy in osteosarcoma.

Yoshinori Uchihara, Katsutsugu Umeda, Yosuke Yamada

Pageof 2

Frequent Collaborators

2 joint publications

Takashi Kohno

2 joint publications

Kan Yonemori

1 joint publications

Hisaki Aiba

1 joint publications

Shu Yazaki